Bitchute Telegram Feed

President Trump Threatens to Fire FDA Chief Unless He Approves Pfizer COVID Vaccine Immediately

Multiple news outlets reported today that the White House has informed the FDA that if they do not approve the new experimental Pfizer COVID vaccine by the end of the day today, Friday, December 11, 2020, that Stephen Hahn, the head of the FDA, would be fired. This follows a Twitter storm by the President earlier in the day where he Tweeted: "While my pushing the money drenched but heavily bureaucratic @US_FDA saved five years in the approval of NUMEROUS great new vaccines, it is still a big, old, slow turtle. Get the dam vaccines out NOW, Dr. Hahn @SteveFDA. Stop playing games and start saving lives!!! The Swine Flu (H1N1), and the attempt for a vaccine by the Obama Administration, with Joe Biden in charge, was a complete and total disaster. Now they want to come in and take over one of the “greatest and fastest medical miracles in modern day history.” I don’t think so! I just want to stop the world from killing itself!" Health Impact News opposes the President 100% on this issue, as we, along with many other organizations, have called upon the FDA to NOT approve the dangerous new Pfizer COVID vaccine that literally thousands of medical doctors and scientists around the world have said is too dangerous to approve, as it will result in deaths, brain injuries, autoimmune diseases, infertility and more.

Read More

FDA could Approve “at least one” COVID-19 Vaccine Before November Election

The pharmaceutical industry's marketing trade publication, FiercePharma, published an article this week where analysts predicted that the U.S. Food and Drug Administration could approve "at least one" new COVID 19 vaccine before the November elections. FDA chief Stephen Hahn, however, testified before the House Energy and Commerce Committee yesterday (June 23, 2020), and stated that the FDA was breaking from the White House's "Warp Speed" timeline for vaccine development, stating that "data and science" would drive the agency's decision making. Hahn was responding to a Congressional inquiry, with a letter being sent to him by three chairs from the House Committee on Oversight and Reform who were concerned about the safety of a "fast-tracked" vaccine. This begs the question, considering that more than $1 TRILLION has already been spent by the U.S. Government to develop COVID vaccines, who is calling the shots here on the COVID vaccine? President Trump has publicly endorsed the "Operation Warp Speed" COVID vaccine project, which is run by a military general and medical authorities all with ties to Bill Gates. Stephen Hahn is President Trump's hand-picked man to run the FDA, coming out of a career in cancer research in Texas. So as America and the world look to the future and a possible COVID vaccine that some doctors claim will be a new kind of DNA vaccine never before used on humans that could have devastating results with many lives lost or destroyed, will the FDA really be transparent with test results and only rely on "data and science?" Because if so, such a vaccine would probably be years away, and certainly not within this year. And if the FDA does, in fact, take this position, will President Trump, as the commentary in FiercePharma states, "push the FDA behind the scenes to issue an approval or emergency authorization"? I guess it depends on who is calling the shots. Will the President and the FDA, or Bill Gates and his collaborators in the U.S. Government such as Dr. Fauci, Dr. Deborah Birx, CDC Director Robert Redfield, and now Operation Warp Speed Director Dr. Moncef Slaoui, be the ones to make the decision to further advance their goals of reducing the world's population? In fact, I think it is appropriate to ask the question: Is the decision to approve this COVID vaccine a requirement for someone to be elected as President of the United States in November?

Read More

FDA Cover-up? New Data Obtained Shows MMR Vaccine Approved on Clinical Trials of Only 342 Children – Half Suffered Side Effects

As we have previously reported here on Health Impact News, pharmaceutical giant Merck has been fighting a criminal case regarding its MMR (Measles, Mumps, Rubella) vaccine in court for over 8 years, as their own scientists became whistle-blowers regarding fraud in the development of the vaccine. Now, Del Bigtree, founder of the non-profit Informed Consent Action Network (ICAN), has announced that a new Freedom of Information Act disclosure from the Federal Food and Drug Administration (FDA) has revealed that the MMR vaccine was licensed based on clinical trials which in total had less than 1,000 participants, and only 342 children. “Thanks to the laws in this country that for now at least permit access to various government records, we now know the MMR vaccine was licensed using an irresponsibly small and limited group of children,” says Bigtree. “But what’s even more alarming is learning about the serious adverse events that were known and acknowledged, yet ignored in order to license the MMR vaccine,” Bigtree adds, noting “This was after only tracking adverse events for 42 days after injection – imagine what they might have found had they tracked safety for three years against an appropriate control, like they do for drugs.”

Read More

FDA Committee Chair: “Congress is Owned by Pharma”

Dr. Raeford Brown is a pediatric anesthesia specialist at the UK Kentucky Children’s Hospital. He also chairs the Food and Drug Administration (FDA) Committee on Analgesics and Anesthetics. Dr. Brown has been openly critical of the FDA and their lack of oversight on the pharmaceutical industry, claiming "Congress is owned by pharma.” His comments were recently reported by Adriana Belmonte at Yahoo Finance. "Pharmaceutical companies are under the spotlight with congressional hearings on the cost of drug prices and allegations of the industry’s role in the opioid crisis. Dr. Raeford Brown, a pediatric anesthesia specialist at the UK Kentucky Children’s Hospital and chair of the Food and Drug Administration (FDA) Committee on Analgesics and Anesthetics, has been openly critical of big pharma and the lack of proper oversight from the FDA. Despite many politicians, particularly declared presidential candidates, beginning to speak out against big pharma, Brown does not think that anything will come out of it 'because Congress is owned by pharma.'" The article documents how pharmaceutical companies are making significant financial contributions to politicians and political candidates. Statistics are based on OpenSecrets, a website operated by the nonpartisan Center for Responsive Politics, which tracks money in U.S. politics. “The pharmaceutical industry pours millions of dollars into the legislative branch every single year,” he told Yahoo Finance. “In 2016, they put $100 million into the elections. That’s a ton of money.” Dr. Brown went on to say: “I’m really much more concerned because Congress is supposed to have oversight for the FDA. If the FDA isn’t going to hold pharma accountable, and Congress is getting paid to not hold pharma accountable, then it really doesn’t matter who the president is because it’s really about Congress.”

Read More

Will New FDA Approval of Gardasil Vaccine for Adults Lead to Mandatory Gardasil Vaccination?

After the U.S. Food and Drug Administration’s (FDA) approved Merck’s HPV-9 Gardasil vaccine for use in adults age 27 to 45 in 2018, the Centers for Disease Control’s (CDC) Advisory Committee on Immunization Practices (ACIP) of the Department of Health and Human Services (HHS) is evaluating whether to expand their current HPV vaccine recommendation to include this new age group. ACIP’s current recommendation is that boys and girls ages 9 through 15 should get two-doses of HPV-9. The “catch-up” vaccine schedule is a three- dose series for females above age 15 through age 27 and males above 15 years of age to 21 years of age, if not previously vaccinated with HPV vaccine. Should ACIP expand their recommendations for use of HPV-9 vaccine in the newly approved age group, the CDC won’t be alone in the push to increase the use of the HPV vaccine by children and adults in the U.S. During the September meeting of the National Vaccine Advisory Committee (NVAC), a federal advisory committee that makes recommendations to the National Vaccine Program Office (NVPO), the HHS Assistant Secretary ADM Brett Giroir M.D. emphasized that HHS supported the NVAC’s HPV vaccine recommendations published in June 2018. Dr. Giroir stated that increasing HPV vaccination in America would be a focus for HHS in 2019. The federal government’s focus on increasing the use recommendations for the HPV vaccine may result in a renewed effort by state legislators to introduce legislation in many states to mandate HPV vaccine for school entry.

Read More

BREAKING: FDA Sued as CDC Recommends Untested, Unlicensed Flu Vaccine for Pregnant Women

In response to a Freedom of Information Act (FOIA) lawsuit, the FDA has admitted, for the first time, that government agencies, including the CDC, are recommending vaccines for pregnant women that have neither been licensed for pregnant mothers by the FDA nor tested for safety in clinical trials. The lawsuit, filed by Children’s Health Defense (CHD) attorney, Robert F. Kennedy, Jr. on behalf of Informed Consent Action Network (ICAN), a vaccine safety advocacy group, sought all clinical trial data used by FDA to approve influenza vaccines for pregnant women. The FDA’s terse reply: “We have no records responsive to your requests.” Robert F. Kennedy, Jr. says, “As a nation, we can no longer pretend our trusted agencies are protecting our children. It is time to hold federal agencies accountable.”

Read More

Public Petitions FDA to Investigate Gardasil Vaccine Fraud

The following open letter to FDA Commissioner, Dr. Scott Gottlieb, calling for immediate investigations into many facets of the clinical trials for Gardasil sponsored by Merck was emailed today. Dear Dr. Gottlieb: This open letter, written on behalf of medical consumers around the world, is an urgent request for you to investigate potential malfeasance perpetrated by Merck during their clinical trials of Gardasil, the human papillomavirus vaccine that the FDA approved in June 2006. A new book, The HPV Vaccine on Trial: Seeking Justice for a Generation Betrayed, by Holland, Rosenberg, and Iorio, outlines at least four areas requiring the FDA’s urgent attention.

Read More

FDA Decision to Approve Gardasil Vaccine for Adults Will Likely Increase Cervical Cancer Rates

The HPV vaccine was just approved for adults, despite Merck’s concerning research data. The FDA made its determination in the face of substantial evidence of the dangers of the HPV vaccine and the existence of safer alternatives. For women who have already been exposed to certain strains of the HPV virus, vaccination can actually increase the risk of precancerous lesions by 44.6%. That’s right: if you are already infected with HPV, getting vaccinated could increase your risk of getting cancer. To put this in perspective, 79 million Americans are thought to be infected with HPV, and about 14 million are newly infected each year, making HPV the most common sexually transmitted infection. Often there are no symptoms. The CDC says that “HPV is so common that almost every person who is sexually active will get HPV at some time in their life.” A large, government-backed push to get more people vaccinated for HPV could actually increase many people’s risk of getting cancer.

Read More

FDA Approves Experimental Hepatitis B Vaccine for Adults Despite Higher Incidence of Heart Attacks

In February 2018, the FDA and CDC approved the recommendation for a new hepatitis B vaccine, Heplisav-B targeting adults over the age of 18. The U.S. Food and Drug Administration (FDA) had twice rejected the application for licensure for Heplisav-B in the past four years because of safety signals. Heplisav-B differs from other licensed hepatitis B vaccines in that it contains a new synthetic adjuvant known as cytosine phosphoguanine 1018 (CpG 1018) composed of short synthetic DNA molecules. In 2016, the FDA rejected an application for licensure for the Heplisav-B vaccine, because the agency was concerned about an increased rate of heart attacks and deaths in people who had been given the vaccine. During the trial, approximately 14 subjects had heart attacks. In July 2017, the FDA committee convened to re-evaluate the scientific evidence and make a decision on whether Heplisav B should or should not be approved for use in the U.S. This committee had only one cardiologist on the team, Milton Packer, MD, who is a distinguished scholar in cardiovascular science at the Baylor University Medical Center in Dallas, Texas. According to Dr. Packer, it was possible that the Heplisav B vaccine’s novel adjuvant was related to the higher number of heart attacks in study participants who received the experimental vaccine. He stated: "To know if the 7 -1 heart attack imbalance represented a real risk, we’d need comparative data in 50,000 people." However, the only way to conduct such a large trial would be to approve the vaccine and see what happens in the public. With Dr. Packer abstaining in his vote to recommend the vaccine, the FDA committee approved it anyway. Dr. Packer stated: "Why did I abstain? Based on the available data, it was impossible for anyone to know if the increase in heart attack risk was real. There is a simple rule in life: if you don’t know, you should say you don’t know." The vaccine is now available to the public, and all those who receive it are basically guinea pigs to find out if heart attacks will result from the experimental vaccine, and if it will continue to have FDA approval.

Read More

The U.S. Needs an Independent Vaccine Safety Organization Separate from the Corrupt FDA and CDC

Most Americans are oblivious to the huge annual burden of chronic illness, injuries and deaths linked to vaccines. Some of the blame for the public’s ignorance belongs to a complicit media that “pretends that vaccine-related injuries do not occur.” However, the lion’s share of culpability for the buried story likely rests with the two federal agencies charged with vaccine oversight—the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC)—both of which regularly engage in various forms of deception to uphold their bland narrative that vaccines are unambiguously safe. One of the most significant criticisms has to do with the FDA’s and CDC’s business-as-usual reliance on external experts with financial ties to the pharmaceutical companies and/or products that they are evaluating. Little has changed since a congressional Committee on Government Reform outlined this problem nearly two decades ago. The Reform Committee examined the doings of the FDA’s Vaccine and Related Biological Products Advisory Committee (VRBPAC), which determines whether new vaccines should be licensed, and the CDC’s Advisory Committee on Immunization Practices (ACIP), which recommends vaccines for inclusion in the childhood vaccine schedule. The congressional committee noted that FDA and CDC advisory committee members and chairpersons own stock in the vaccine companies under consideration, as well as own vaccine patents. The CDC “grants conflict of interest waivers to every member of their advisory committee a year at a time and allows full participation in the discussions leading up to a vote by every member,” even if a member has a financial stake in the decision.

Read More